Skip to main content
Clinical Trials/NCT06413888
NCT06413888CompletedNot Applicable

Routine Nasogastric Drainage vs. No Drainage Using Nasogastric Tube After Pancreaticoduodenectomy: A Randomized Control Trial [NCT ID Not Yet Assigned]

Baylor College of Medicine1 site in 1 country230 target enrollmentStarted: June 1, 2018Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
230
Locations
1
Primary Endpoint
to assess whether nasogastric decompression following a whipple procedure will reduce the incidence and severity of postoperative complications

Study Overview

Brief Summary

Pancreaticoduodenectomy (PD) remains the gold-standard operation for peri-ampullary neoplasms. Traditionally, gastric decompression via nasogastric intubation has been employed postoperatively to prevent nausea, vomiting, aspiration pneumonia, anastomotic leakage and delayed gastric emptying. Recently, the implementation of ERAS protocol recommended against routine use of nasogastric tube following PD. however, limited data exists surrounding the identification of those patients needing NGT decompression in the immediate postoperative period. Therefore, we initiated a large prospective randomized controlled trial to evaluate the clinical outcomes of patients who retained the NGT post-PD versus those who had it removed at the end of the procedure. This study aims to assess the effectiveness of nasogastric decompression in PD recovery, with the primary endo point being the need for and impact of NGT in the postoperative recovery. The secondary endpoint will examined the re-insertion rate of NGT and identify factors that necessitate its use in the immediate postoperative period.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •All patients 18 years of age or older
  • •Patients undergoing successful pancreaticoduodenectomy for benign or malignant neoplasm.

Exclusion Criteria

  • •Patients who does not complete the procedure due to locally advanced or metastatic disease discovered during the procedure.
  • •Patient who requires prolong postoperative intubation in the postoperative period.

Arms & Interventions

Group A ( No NGT)

Active Comparator

Intervention: pancreaticoduodenectomy (Procedure)

Group B (NGT Retained)

Active Comparator

Intervention: pancreaticoduodenectomy (Procedure)

Outcomes

Primary Outcomes

to assess whether nasogastric decompression following a whipple procedure will reduce the incidence and severity of postoperative complications

Time Frame: 30-days postoperatively

Severity of post operative complications was graded according to the Clavien-Dindo classification system adopted for pancreaic surgery, which relies on the type of treatment used for each complication with scores range from 1-4, and any complication graded \>2 considered a major complication.

Secondary Outcomes

  • identify factors that necessitated its use in the immediate postoperative period(30 days postoperatively)
  • Examined the re-insertion rate of Nasogastric tube following pancreaticoduodenectomy(30- days postoperatively)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Omar Barakat

Associate Professor

Baylor College of Medicine

Study Sites (1)

Loading locations...

Similar Trials